Heart Failure Therapeutics Market, Global Outlook and Forecast 2023-2032
Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
This report aims to provide a comprehensive presentation of the global market for Heart Failure Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Therapeutics. This report contains market size and forecasts of Heart Failure Therapeutics in global, including the following market information:
Global Heart Failure Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Heart Failure Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnosis Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Heart Failure Therapeutics include Bayer, Cynokinetics, Les Laboratoires Servier, Merck & Co., Novartis, Procoralan, Bristol-Myers Squibb Company, Cardiorentis AG and CVie Therapeutics Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Heart Failure Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heart Failure Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Heart Failure Therapeutics Market Segment Percentages, by Type, 2022 (%)
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Global Heart Failure Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Heart Failure Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Medical Research Organization
Global Heart Failure Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Heart Failure Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heart Failure Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Heart Failure Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Outline of Major Chapters:
Chapter 1: Introduces the definition of Heart Failure Therapeutics, market overview.
Chapter 2: Global Heart Failure Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Heart Failure Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Heart Failure Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
